nishithadmin
-
11 February 2026 at 11 : 17 AM
Tax Hotline: ITAT allows scheme of AIF to avail pass-through exemption despite having a separate PAN
Read MoreFebruary 11, 2026 ITAT allows scheme of AIF to avail pass-through exemption despite having a separate PAN An AIF scheme is entitled to exemption under section 10(23FBA) even if SEBI registration is in the name of the parent trust and not in the scheme’s own PAN. Differences arising due to statutory indexation cannot be […]
-
10 February 2026 at 17 : 55 PM
Yes, Governance Matters.: Why Same-Day Board and AGM Meetings Invite Regulatory Scrutiny
Read MoreFebruary 10, 2026 Why Same-Day Board and AGM Meetings Invite Regulatory Scrutiny This article was first published in www.taxsutra.com (Feb, 06, 2026). The Registrar of Companies, Karnataka (“RoC”) passed an Adjudication Order[1] Section 454 of Companies Act, 2013 (“CA 2013”) imposing penalties on Stanley OEM Sofas Limited, a public limited company and wholly owned […]
-
10 February 2026 at 11 : 02 AM
Tax Hotline: Tiger Global Investment: Rewriting the Rules of India’s International Tax Regime
Read MoreFebruary 10, 2026 Tiger Global Investment: Rewriting the Rules of India’s International Tax Regime Prima facie tax avoidance may be inferred wherever a transaction seeks to avoid a tax otherwise payable under law. Considering the introduction of the GAAR, a tax residency certificate, by itself, is no longer sufficient to establish residence under the […]
-
9 February 2026 at 12 : 41 PM
Pharma & Healthcare Update: Fast-Tracking Clinical Research: India’s New Approval Regime
Read MoreFebruary 09, 2026 Fast-Tracking Clinical Research: India’s New Approval Regime New Drugs and Clinical Trials Rules, 2019 amended to introduce a ‘prior intimation’ regime for specified categories of new drugs, investigational new drugs and unapproved APIs The amendments reduce regulatory timelines from 90 to 45 working days for grant of permissions and introduce deemed […]
-
9 February 2026 at 09 : 38 AM
Regulatory Hotline: DPIIT’s New Startup Framework: Deep Tech Startup Recognition and Key Reforms
Read MoreFebruary 09, 2026 DPIIT’s New Startup Framework: Deep Tech Startup Recognition and Key Reforms DPIIT has issued a landmark notification on February 6, 2026, replacing the 2019 framework and, for the first time, formally recognising and defining Deep Tech Startups in India. The new framework expands eligibility by extending deep tech recognition up to […]
-
4 February 2026 at 18 : 49 PM
Pharma & Healthcare Update: Budget 2026-2027: Key Initiatives in The Pharmaceutical and Healthcare Industry
Read MoreFebruary 04, 2026 Budget 2026-2027: Key Initiatives in The Pharmaceutical and Healthcare Industry The Finance Bill 2026–2027 (“Budget”) underscores the Government’s continued focus on strengthening India’s pharmaceutical, healthcare, and life sciences ecosystem through targeted policy interventions, fiscal support, and regulatory reforms. With an emphasis on innovation, domestic manufacturing, R&D, and access to affordable healthcare, […]
-
2 February 2026 at 16 : 54 PM
India Budget Analysis 2026-27
Read MoreFor International Business Community February 02, 2026 Budget Miss: Why India Needs Big-Bang Reforms to Win Global Markets India’s recent Budget, like several before it, has focused on micro-reforms—rationalising rates, simplifying tax procedures, improving ease of doing business, and digitising compliances. These steps were necessary and constructive. They have stabilised the macroeconomy, strengthened tax […]
-
31 January 2026 at 16 : 01 PM
Tax Hotline: Tax tribunal holds conversion of OCCRPS into equity does not trigger taxation under section 56(2)(x)
Read MoreJanuary 31, 2026 Tax tribunal holds conversion of OCCRPS into equity does not trigger taxation under section 56(2)(x) In a significant ruling for the taxation of hybrid securities, a Mumbai Bench of the Income Tax Appellate Tribunal (“Tribunal”) has held that the conversion of optionally convertible cumulative redeemable preference shares (“OCCRPS”) into equity shares does […]
-
30 January 2026 at 15 : 27 PM
Pharma & Healthcare Update: Cutting the Red Tape: Relaxed Approval Requirements for Drug Studies
Read MoreJanuary 30, 2026 Cutting the Red Tape Relaxed Approval Requirements for Drug Studies The Ministry of Health and Family Welfare has amended the New Drugs and Clinical Trials Rules, 2019 to introduce a permission-free pathway for certain BA/BE studies conducted exclusively for export purposes. The amendment replaces the requirement of prior regulatory approval with […]
-
29 January 2026 at 12 : 06 PM
M&A Hotline: Deal-Making Landscape in India in 2026: Trends, Developments and Considerations
Read MoreJanuary 29, 2026 Deal-Making Landscape in India in 2026: Trends, Developments and Considerations INTRODUCTION Global deal-making in 2025 demonstrated resilience and, by several metrics, surpassed prior years’ activity despite macroeconomic and geopolitical uncertainties. Total global mergers and acquisitions (“M&A”) value for the first nine months of 2025 rose approximately 10% year-on-year1, extending a recovery […]
-
14 January 2026 at 10 : 13 AM
Regulatory Hotline: SEBI Facilitates Seamless DSC Functionality: A Step Towards Paperless Onboarding
Read MoreJanuary 14, 2025 SEBI Facilitates Seamless DSC Functionality: A Step Towards Paperless Onboarding for FPIs SEBI has operationalised DSC-based digital execution on the NSDL FPI Portal, enabling largely paperless filing and signing of the CAF and other FPI onboarding documents. The integrated DSC is expected to significantly reduce registration timelines and cross-border logistical friction […]
-
12 January 2026 at 09 : 45 AM
Technology Law Analysis: 2025: The Year That Was in Technology, Media & Telecommunications Law and Policy in India
Read MoreJanuary 12, 2025 2025: The Year That Was in Technology, Media & Telecommunications Law and Policy in India 2025 was monumental year for the Technology, Media and Telecom (“TMT“) sector in India. From long-awaited legislative reforms to decisive policy interventions, the year reflected India’s intent to simultaneously strengthen digital rights, manage emerging risks and […]
-
7 January 2026 at 11 : 15 AM
Pharma & Healthcare Update: Regulatory Wrap 2025: Food Industry in India
Read MoreJanuary 07, 2025 Regulatory Wrap 2025: Food Industry in India The most significant regulatory developments in India’s food sector in 2025 include: The Food Safety and Standards Authority of India discontinues “100%” claims on food labels and promotions. Food safety surveillance strengthened through QR-code integration and updated disposal norms. Environmentally compliant disposal norms issued […]
-
6 January 2026 at 12 : 41 PM
Pharma & Healthcare Update: Regulatory Wrap 2025: Medical Devices Industry in India
Read MoreJanuary 06, 2025 Regulatory Wrap 2025: Medical Devices Industry in India The most significant regulatory developments in India’s medical-devices sector in 2025 include: Digital pathways introduced for risk classification and import of approved medical devices. Regulatory measures impacting pricing, labelling and export facilitation for medical devices introduced. Draft guidance issued for regulation of software-based […]
-
5 January 2026 at 11 : 09 AM
Pharma & Healthcare Update: Regulatory Wrap 2025: Pharmaceutical Industry in India
Read MoreJanuary 05, 2025 Regulatory Wrap 2025: Pharmaceutical Industry in India The most significant regulatory developments in the Indian pharmaceutical industry in 2025 are: The Drugs and Cosmetics (Compounding of Offences) Rules, 2025 notified. DOP issued circular clarifying pharmaceutical marketing practices. CDSCO reiterates mandatory testing of raw materials and finished formulations. CDSCO issued guidance document […]
-
22 December 2025 at 19 : 34 PM
Regulatory Digest: The Financial Services Bulletin
Read MoreDecember 22, 2025 The Financial Services Bulletin This is the December edition of Nishith Desai Associates’ monthly financial services newsletter in collaboration with U.S.-India Business Council. INTRODUCTION The last month continued to solidify India’s position as the world’s fastest-growing major economy, driven by accelerated domestic expansion and macroeconomic stability. Real GDP growth surged to […]
